Cocrystal Pharma (NASDAQ:COCP) Shares Up 13.6%

Cocrystal Pharma, Inc. (NASDAQ:COCPGet Free Report) shares shot up 13.6% during trading on Thursday . The stock traded as high as $2.74 and last traded at $2.59. 140,214 shares were traded during mid-day trading, an increase of 596% from the average session volume of 20,140 shares. The stock had previously closed at $2.28.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and issued a $10.00 price target on shares of Cocrystal Pharma in a report on Tuesday, May 14th.

Read Our Latest Stock Analysis on Cocrystal Pharma

Cocrystal Pharma Price Performance

The firm’s 50-day moving average is $1.76 and its 200-day moving average is $1.67.

Cocrystal Pharma (NASDAQ:COCPGet Free Report) last issued its quarterly earnings data on Monday, May 13th. The company reported ($0.39) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.54) by $0.15. Equities analysts forecast that Cocrystal Pharma, Inc. will post -2.02 earnings per share for the current year.

About Cocrystal Pharma

(Get Free Report)

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.

Recommended Stories

Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.